# Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (Text with EEA relevance), Division 3.3

Extent: E+W+S+N.I.

For veterinary medicinal products containing an active substance which is the subject of an application for marketing authorisation in any Member State for the first time, the quantitative statement of an active substance which is a salt or hydrate shall be systematically expressed in terms of the mass of the active entity or entities in the molecule. All subsequently authorised veterinary medicinal products in the Member States shall have their quantitative composition stated in the same way for the same active substance.

---
Source: https://www.legislation.gov.uk/eur/2019/6/annex/II/title/I/part/2/division/A/division/3/division/3.3 (the official version)
Page: https://openlegislation.uk/eu-regulation-2019-6/annex-II/title-I/part-2/division-A/division-3/division-3.3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.